Axsome reports third-quarter 2026 results, starts Phase 3 smoking cessation trialNov 2Quarterly updateAxsome Therapeutics, Inc.dextromethorphan-bupropion
Axsome posts ADVANCE-2 agitation results; smoking cessation trial recruitingAug 14Weekly roundup, 2 itemsAxsome Therapeutics, Inc.dextromethorphan-bupropion
Axsome reports 2Q 2026 results, Alzheimer's agitation launch, AXS-12 NDA acceptedAug 10Quarterly updateAxsome Therapeutics, Inc.solriamfetol